About metaLead Therapeutics
metaLead Therapeutics is a company based in Zurich (Switzerland) founded in 2022 by Michal Shoshan. metaLead Therapeutics has raised $170.02 thousand across 2 funding rounds from investors including Venture Kick.
- Headquarter Zurich, Switzerland
- Founders Michal Shoshan
-
Sectors
Healthcare
-
Phone
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$170.02 K (USD)
in 2 rounds
-
Latest Funding Round
$159.94 K (USD), Seed
Mar 10, 2023
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of metaLead Therapeutics
metaLead Therapeutics has successfully raised a total of $170.02K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $159.94 thousand completed in March 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in metaLead Therapeutics
metaLead Therapeutics has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Venture Kick.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
University backed startup accelerator
|
Locked | Locked | Locked |
Investor details for metaLead Therapeutics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by metaLead Therapeutics
Investment portfolio details for metaLead Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - metaLead Therapeutics
Detailed financials for metaLead Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Metalead Therapeutics Comparisons
Peer comparison for metaLead Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of metaLead Therapeutics
Detailed competitors of metaLead Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Metalead Therapeutics
Complete news archive for metaLead Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about metaLead Therapeutics
metaLead Therapeutics was founded in 2022.
metaLead Therapeutics is headquartered in Zurich, Switzerland.
metaLead Therapeutics is a funded company, having raised a total of $170.02K across 2 funding rounds to date.
MetaLead Therapeutics was founded in 2022 in Zurich, Switzerland, within the biotechnology sector. Focus is placed on developing treatments for metal poisoning, with operations centered on chelation therapy. The lead compound targets lead (Pb) toxicity, which remains the primary treatment approach. Research and development activities are conducted to advance therapeutic options for heavy metal exposures.
metaLead Therapeutics has 1 investor. Key investors include Venture Kick.